United Kingdom · Question · Written question
UIN 34601
Coronavirus: Immunotherapy
Original
Introduced
16 July 2021
Last action
27 July 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
27 July 2021
Summary
To ask the Secretary of State for Health and Social Care, what steps he is taking to assist the Medicines and Healthcare products Regulatory Agency to progress the licensing process for the REGEN-COV, Regeneron, monoclonal antibody treatment.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
16 July 2021
Written question
To ask the Secretary of State for Health and Social Care, what steps he is taking to assist the Medicines and Healthcare products Regulatory Agency to progress the licensing process for the REGEN-COV, Regeneron, monoclonal antibody treatment.
Source: Commons
27 July 2021
Answer
The Medicines and Healthcare products Regulatory Agency’s (MHRA) licensing of therapeutics, including for REGEN-COV, is an independent process. The Therapeutics Taskforce encourages companies seeking approvals for COVID-19 therapeutics to provide the data...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-07-16/34601
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1347701
- uk · wq-1347701 · source updated 27 July 2021